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SUMMARY 
Structural pathology and outcome were studied in 170 chromosomally abnormal fetuses. Numerical chromosomal 
abnormalities were established in 158 (93 per cent) cases, of which 110 (71 per cent) represented trisomies, 30 (18 per 
cent) Turner syndrome, and 18 (1 1 per cent) triploidy. Structural chromosomal abnormalities were diagnosed in 12 
(7 per cent) cases. Gestational age at referral was significantly shorter for pregnancies with Turner syndrome than 
for the other chromosomal abnormalities. Referral before 20 weeks of gestation was mainly based on fetal structural 
pathology alone (92 per cent); after 20 weeks, patients were referred because of structural pathology combined with 
small for gestational age, oligohydramnios, or polyhydramnios. Referral as a result of suspected multiple organ 
pathology occurred in 73-5 per cent of pregnancies. An abnormal amniotic fluid volume was present in 59/170 (34.5 
per cent) chromosomally affected pregnancies, i.e., oligohydramnios in 31 and polyhydramnios in 28 cases. Birth 
weight was below the tenth percentile in over half of the chromosomally abnormal fetuses, except for Turner 
syndrome. Fetal outcome was poor, with a survival rate at 1 month of 30 per cent for trisomies which was mainly 
determined by trisomy 21 (14/18=775 per cent). 
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INTRODUCTION 
The majority of chromosomally abnormal 
fetuses will present with single or multiple struc- 
tural defects (Wladimiroff et al., 1985). Different 
chromosomal abnormalities may present with dif- 
ferent subsets of anomalies. The effectiveness of 
anomaly scanning in low-risk populations has 
been variable, with detection rates between 40 
and 85 per cent (Campbell and Smith, 1983; 
Saari-Kemppainen et al., 1990; Levi et al., 1991). 
This will determine the referral rate to a centre for 
prenatal diagnosis, where further sonographic 
analysis of the suspected anomalies and, if 
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necessary, karyotyping will take place. Early 
detection of a chromosomal anomaly improves 
obstetric management, with termination of preg- 
nancy as an option if a major chromosomal defect 
is found (Palmer et al., 1987; Rizzo et al., 1990). 
The objective of the present study was to deter- 
mine (i) the reasons for referral, (ii) the nature of 
the ultrasonographically detectable fetal structural 
pathology, and (iii) the fetal outcome in 170 
chromosomally affected pregnancies. 
MATERIALS AND METHODS 
Between 1 January 1983 and 1 January 1993, 
3840 pregnant women were referred from district 
hospitals to the Division of Prenatal Diagnosis 
of the Academic Hospital Rotterdam-Dijkzigt 
because of suspected fetal structural pathology 
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alone or in combination with small for gestational 
age/oligohydramnios or polyhydramnios. Gesta- 
tional age ranged between 15 and 37 weeks (mean 
26 weeks) and was determined from the last 
menstrual period. In cases of uncertain dates or a 
discrepancy with ultrasound, the fetal crown- 
rump length or biparietal diameter determined the 
gestational age. 
A detailed anomaly scan was performed to 
determine the nature, extent, and severity of the 
structural anomaly and to identify possible associ- 
ated malformations. Small for gestational age 
(SGA) was defined as an upper abdominal circum- 
ference below the tenth centile (Campbell and 
Wilkin, 1975) andor a birth weight below the 
tenth centile according to the Kloosterman tables 
(Kloosterman, 1970), corrected for maternal parity 
and fetal sex. Oligohydramnios was defined as a 
largest fluid pool of 2 cm or less; polyhydramnios 
was defined as a largest fluid pool of 8 cm or more. 
Couples were counselled regarding the possible 
association with chromosomal defects and the 
risks and benefits of the different sampling proce- 
dures. Skeletal dysplasias and spina bifida without 
other structural pathology were the most common 
single-system anomalies for which karyotyping 
was not offered. The results of the ultrasound 
examinations and fetal karyotype were given to the 
referring obstetricians, who undertook the further 
management of the patients. Details on the out- 
comes of the pregnancies were obtained from the 
referring hospitals. 
A total of 1410 patients opted for fetal karyo- 
typing, of which 170 (12 per cent) demonstrated an 
abnormal fetal chromosome pattern. Data are 
presented from these 170 patients, in which cyto- 
genetic analysis was carried out from amniotic 
fluid (n= 101), chorionic villi (n=33), or fetal blood 
(n= 36). Fifty-two patients refused fetal karyo- 
typing, of which five delivered an infant with 
trisomy. 
Statistical analysis was carried out using the 
Wilcoxon rank s u m  test for establishing differences 
in maternal and gestational age at referral between 
the various chromosomal anomalies. The chi- 
square test was used to compare the detection rate 
of chromosomal anomalies based on single-organ 
structural pathology before and after 20 weeks of 
gestation. This cut-off point was chosen since a 
fetal scan is advised at 16-20 weeks by the pro- 
fessional organization in The Netherlands. An 
established screening programme, however, does 
not exist. 
RESULTS 
Numerical chromosomal abnormalities were 
found in 158 (93 per cent) cases, of which 17 (11 
per cent) were trisomy 13, 51 (33 per cent) trisomy 
18, 42 (27 per cent) trisomy 21, 30 (18 per cent) 
Turner syndrome, and 18 (11 per cent) triploidy. 
Structural chromosomal abnormalities were diag- 
nosed in 12 (7 per cent) cases (Table I). All 
chromosomal anomalies were confirmed post- 
natally. Sonographically determined anomalies 
were confirmed postnatally, although there was 
slight misclassification within the affected organ 
system (for instance, partial vs. complete atrioven- 
tricular septal defect; meningocoele vs. meningo- 
myelocoele) in 12 cases. Additional minor 
anomalies (small ventricular or atrial septal defect, 
oesophageal atresia, cleft palate, etc.) were missed 
in 11 cases. 
The mean maternal age ( f 1 SD) and the mean 
gestational age ( f 1 SD) for each of the chromo- 
somal abnormalities at referral are shown in Table 
11. Maternal age at referral was significantly lower 
for Turner syndrome compared with trisomy 21 
(PCO.001) and trisomy 18 (P<0.05). Also, mater- 
nal age in cystic hygroma associated with Turner 
syndrome (n=23; 28.93~444 (SD) years) was sig- 
nificantly lower (P<O.OOl) compared with cystic 
hygroma associated with trisomy (n= 14,36-4 f 5.6 
(SD) years). Gestational age at referral in Turner 
syndrome was signilicantly lower compared with 
trisomies 21 and 18 (PCO.OOl), trisomy 13 and 
triploidy (P<O.Ol), and structurally abnormal 
chromosomes (Pc0.001). 
Reasons for referral to our division of prenatal 
diagnosis are given in Table 111. Referral before 20 
weeks of gestation took place in 64 (39 per cent) 
pregnancies and after 20 weeks in the remaining 
106 (61 per cent) pregnancies. Before 20 weeks of 
gestation, referral was mainly based on fetal 
structural pathology alone (59/64=92 per cent); 
after 20 weeks, patients were referred because of 
structural pathology alone (47/106=44 per cent) or 
structural pathology in combination with small 
for gestational age (SGA), oligohydramnios or 
polyhydramnios (59/106=56 per cent). 
Chromosome analysis was performed because of 
single or multiple structural anomalies (Table IV). 
Referral as a result of a suspected single-organ 
anomaly occurred in 45/170 (26-5 per cent) preg- 
nancies and as a result of suspected multiple-organ 
pathology in the other 125/170 (73.5 per cent) 
pregnancies. An abnormal chromosome pattern 
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Table 1-Fetal structural chromosomal abnormalities in 12 pregnancies presenting with 
sonographic fetal malformations 
Type of chromosomal abnormality n Fetal karyotype 
Balanced familial reciprocal 3 
translocation 
De novo reciprocal transloation 2 
Unbalanced familial reciprocal 4 
translocation 
Unbalanced de novo reciprocal 2 
translocation 
De novo deletion 1 
46,XX,t( 1 1;13)(q21;q22.2)pat 
46.XY,t(1;6)(ql l;q21.3)pat 
46,XY,t(2;19)(p16;q13.2)mat 
46,XX,t( 1; 16)(q21;q24) 
46,XY,t( 1; 18)(p21;q23) 
46,XY, - 8,+rec(8),t(8;1 l)*mat 
46,XX, - 18, +der(18),t(7;18)(q21;q21.3)mat 
47,XY, + der(g),t(6;9)(q23;q21.2)mat 
46,XY, - 7, +der(7),t(7; 12)(q34;p13)pat 
46,XY, - 4, + der(4) 
FISH:46,XY, - 4,+der(4),t(4;11) 
not further determined 
46,XX,de1(5)@15.2) 
46,XX, - 15,+15p+ 
Fetal karyotype: 46,XY, - 8,+rec(8)(8qter-+8p23::1 1 ~ 2 1 -  1 Iqter),t(8;1l)mat. 
Maternal karyotype: 46,XX,t(8;11)(8q12-.8p23::1 lq21-+11qter;l Ipter-+ll 21::8q1243qter)mat 
(Los et aZ., 1992). 
Table II-Maternal age (XiSD) and gestational age (XiSD)  at referral in 170 chromosomally affected 
pregnancies 
Trisomy 
45,X Triploidy Structural chromosomal 
13 ( ~ 1 7 )  18 ( ~ 5 1 )  21 ( ~ 4 2 )  (n=30) (n=18) abnormality (n=12) 
Maternal age (years) 30-1 f 6.2 31.3 f 5.2 33.4 f 6.1 28.6 f 4.7 28-6 i 4.2 28.2 f 4.3 
Gestational age (week) 26-1 f 7.5 25.6 f 7.7 25.7 f 7.6 19.7 f 5.1 24.6 i 5.8 27.0 f 5.5 
( X i  1 SD) 
(Xf 1 SD) 
was established in the presence of a single-organ 
anomaly in 26/64 (40.5 per cent) pregnancies 
referred before 20 weeks and in 19/106 (18 per 
cent) pregnancies referred after 20 weeks v = 9 4  
PC0.02). For trisomies alone, this was 22137~60 
per cent vs. 13/60=215 per cent p=19-6; 
P~O~O001). 
The nature of the structural anomalies for each 
of the chromosomal abnormalities is depicted in 
Table V. Abnormalities of the central nervous 
system, renal tract, gastrointestinal tract, heart, 
and skeleton constituted the majority of structural 
pathology and were associated with trisomies 
(28/53=53 per cent at 620  weeks; 148/180=82 per 
cent at >20 weeks), triploidy (100 per cent at 620 
weeks; 17/19=89 per cent at >20 weeks), and 
structural chromosomal abnormalities (100 per 
cent). Within the group of trisomies, the following 
observations were made. Brain and neural tube 
abnormalities were mostly seen in trisomies 13 and 
18, with emphasis on bilateral choroid plexus cysts 
combined with other anomalies and spina bifida in 
trisomy 18 and emphasis on holoprosencephaly 
in trisomy 13. Cardiac septal defects (ventricular 
septal defect, complete atrial ventricular septal 
defect) were seen in trisomies 13, 18, and 21, as 
well as tetralogy of Fallot in trisomy 18. Gastro- 
intestinal anomalies consisted of duodenal atresia 
(double bubble image) in trisomy 21, and om- 
phalocoele was observed in trisomies 13 and 18. 
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Table III-Reasons for referral before and after 20 weeks of gestation in 170 chromosomally affected pregnancies 
structural 
chromosomal Trisomy 
45,X Triploidy abnormality Total 
-~ ~ 
Structural pathology 
< 20 weeks 5 18 13 19 3 1 59 
>20 weeks 8 9 16 7 4 3 47 
Structural pathology+ 
SGNoligohydramnios 
<20 weeks - 1 - 1 2 1 5 
>20 weeks 2 5 4 3 9 3 26 
Structural pathology+ 
polyhydramnios 
< 20 weeks 
>20 weeks 2 18 9 - 4 33 
- - - - - - - 
- 
SGA=Small for gestational age. 
Table IV-The incidence of fetal single and multiple anomalies at referral before and after 20 weeks of gestation 
structural 
Trisomy chromosomal 
45,X Triploidy abnormality Total 
13 (n=17) 18 (n=51) 21 (n=42) (n=30) (n=18) (n= 12) (n= 170) 
Referral <20 weeks 
Structural pathology 
Single anomaly 3 10 9 2 2 26 
38 
- 
- Multiple anomalies 2 9 4 18 5 
Single anomaly - 3 10 - 3 3 19 
Referral >20 weeks 
Structural pathology 
Multiple anomalies 12 29 19 10 10 7 87 
Skeletal anomalies were seen in trisomies 13, 18, 
and 21 , with emphasis on abnormal hand and foot 
position and facial cleft. Micrognathia was associ- 
ated with trisomy 18, while polydactyly was 
associated with trisomy 13. Renal tract pathology 
nearly always constituted bilateral hydronephrosis 
in association with trisomies 13, 18, and 21. 
Miscellaneous anomalies were diaphragmatic 
hernia, two-vessel cord, and oesophageal atresia. 
Cystic hygroma and fetal hydrops were associated 
with Turner syndrome (31/50=62 per cent at <20 
weeks; 14/27=52 per cent at >20 weeks). 
An abnormal amniotic fluid volume was found 
in 59/170 (34.5 per cent) chromosomally affected 
pregnancies. Oligohydramnios was present in 31 
pregnancies, of which 23 (74 per cent) were in the 
referrals beyond 20 weeks of gestation. Oligo- 
hydramnios was diagnosed in only 5/110 (4.5 per 
cent) cases with trisomy, in 4/12 (33 per cent) cases 
with structural chromosomal abnormality, in 
10/29 (34-5 per cent) cases with Turner syndrome, 
and in 12/18 (67 per cent) cases with triploidy. 
Polyhydramnios was present in 28 cases, all 
beyond 20 weeks of gestation. Polyhydramnios 
was diagnosed in 2/18 (11 per cent) cases with 
triploidy, in 23/110 (21 per cent) cases of trisomy, 
and in 3/12 (25 per cent) cases with a structurally 
abnormal chromosome. 
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Table VI-Fetal outcome in 170 chromosomaily affected pregnancies 
Trisomy Structural 
13 18 21 45,X Triploidy abnomality 
chromosomal 
(n=17) (n=51) (n=42) (n=30) (n=18) (n= 12) 
TOP 9 26 14 26 14 6 
IUD 1 7 6 2 4 
6 NND 7 14 8 
Alive at 1 month - 4 14 2 
- 
- - 
- - 
TOP=Termination of pregnancy; IUD=intrauterine death; NND=neonatal death. 
Birth weight was below the tenth percentile in 
4/30 (14 per cent) fetuses with Turner syndrome, in 
6/12 (50 per cent) fetuses with a structural chromo- 
somal abnormality, in 58/110 (53 per cent) fetuses 
with trisomy, and in 16/18 (90 per cent) fetuses 
with triploidy. 
Perinatal outcome is presented in Table VI. 
Excluding the pregnancy terminations, the survival 
rate (at 1 month) for trisomies was 18/61 (30 per 
cent), which was mainly determined by trisomy 21 
(14/18=77-5 per cent). Of these 14 survivors with 
trisomy 21, seven displayed no structural anoma- 
lies and the remaining seven cases were associated 
with duodenal atresia (2), duodenal atresia+ 
ventricular septal defect (VSD) (l), complete atrio- 
ventricular septal defect (l), hydrocephaly+ VSD 
(l), and urethral obstruction + oligohydramnios 
(2). The neonatal survival rate was 50 per cent (2/4) 
for Turner syndrome and none for the remaining 
chromosomal abnormalities. 
DISCUSSION 
It should be emphasized that the present data 
represent a selected group of fetuses with chromo- 
somal abnormalities and are not representative of 
chromosomally abnormal fetuses in general. 
Despite the retrospective nature of the study, a 
number of comments can be made. Cordocentesis 
allows rapid karyotyping, which may be crucial 
during the late second and third trimesters of 
pregnancy when sudden decisions regarding ob- 
stetric management may have to be taken. Never- 
theless, in over half of our cases, amniocentesis 
was performed. This was for the following reasons: 
(i) cordocentesis had not yet been introduced in 
our department before 1987; (ii) cordocentesis was 
not carried out in the presence of a small-for- 
gestational age (SGA) fetus due to the risk of 
further impairment of placental perfusion; (iii) 
cordocentesis often failed as a result of oligo- 
hydramnios or polyhydramnios. 
The percentage of karyotyped patients with an 
abnormal chromosome pattern was 12 per cent, 
which is similar to that reported in the literature 
(Nicolaides et al., 1992). Numerical chromosomal 
abnormalities were established in the vast majority 
of cases (93 per cent), and in particular, trisomies. 
Most chromosomal anomalies were diagnosed 
in referrals beyond 20 weeks of gestation, i.e., 
during the late second and early third trimesters of 
pregnancy. Apart from the psychological impact 
on the parents of such a late diagnosis, termination 
of pregnancy in cases of lethal fetal structural 
pathology is prohibited in The Netherlands 
beyond 24 weeks of gestation. Only fetuses with 
Turner syndrome were diagnosed earlier in preg- 
nancy; 76 per cent (20/30) were found before 20 
weeks. Unusual was the finding of five cases with 
Turner syndrome associated with central nervous 
system anomalies before 20 weeks: encephalocoele 
(I), hydrocephaly (2), and meningomyelocoele (2). 
Diagnosis of this syndrome was mostly based 
on a combination of cystic hygroma and fetal 
hydrops, which produces well-defined sonographic 
images that are subject to early detection. This 
close association between cystic hygroma and fetal 
hydrops has also been reported by others (Azar 
et aZ., 1991). Cystic hygroma combined with fetal 
hydrops was also the most important marker for 
the early diagnosis of trisomy, especially trisomy 
21. However, the majority (75/110=68 per cent) of 
trisomies were detected by multiple structural 
anomalies during late gestation. 
Of interest is the fact that in over half (1 5/23 = 65 
per cent) of the cases with fetal cystic hygroma 
associated with Turner syndrome, the maternal 
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age was below 30 years, as opposed to fetal cystic 
hygroma associated with trisomy, where the 
maternal age was more likely (8/14=57 per cent) to 
be 36 years or older. 
In The Netherlands all women of 36 years and 
older are offered prenatal diagnosis. Approxi- 
mately 30 per cent-of these women do not undergo 
prenatal diagnosis for various reasons. In four out 
of eight women in the present study, the fetal cystic 
hygroma was established prior to a planned chori- 
onic villus sampling or amniocentesis because of 
advanced maternal age. The remaining four 
women (one Dutch, three Mediterranean) did not 
undergo prenatal diagnosis for reasons unknown. 
The reasons for the late diagnosis of chromo- 
somal anomalies other than Turner syndrome are 
several: the apparent lack of clear guidelines as to 
whether and when to perform an anomaly scan in 
district hospitals and the limited capability of the 
referring institution to detect structural anomalies 
before 20 weeks of gestation. T h s  is demonstrated 
by the fact that referrals before 20 weeks were 
predominantly based on a single-organ anomaly, 
whereas after 20 weeks an increasing number with 
multiple-organ pathology were diagnosed, as was 
particularly the case in trisomies. This higher 
pick-up rate of structural pathology after 20 weeks 
is due to the improved visualization of individual 
fetal structures as well as the appearance of associ- 
ated pathology such as oligohydramnios and poly- 
hydramnios later in gestation. It should be pointed 
out, however, that gastrointestinal pathology, in 
particular obstructive pathology, may not display 
itself sonographically until later in pregnancy; this 
was also demonstrated in the present study, in 
which none of the gastrointestinal lesions was 
detected before 20 weeks of gestation. 
The majority of chromosomal abnormalities 
were associated with multiple structural anomalies. 
Whereas most chromosomal abnormalities had 
central nervous system, cardiac, renal tract, and 
skeletal defects in common, there were differences 
in the exact nature of the defects for the different 
chromosomal abnormalities. This was particularly 
so for central nervous system defects with bilateral 
choroid plexus cysts in trisomy 18 and holoprosen- 
cephaly in trisomy 13. Gastrointestinal anomalies 
were represented by duodenal atresia associated 
with trisomy 21. Additional pathology such as 
SGA and abnormal amniotic fluid volume played 
a minor role (5/170=3 per cent) in the early 
diagnosis of chromosomal anomalies. However, 
after 20 weeks of gestation structural pathology 
combined with SGA/oligohydramnios or poly- 
hydramnios was the reason for referral in 15 per 
cent (26/170) and 19 per cent (33/170) of cases, 
respectively. 
Fetuses with triploidy were associated with 
oligohydramnios in 67 per cent but with normal 
amniotic fluid in 22 per cent and with polyhydram- 
nios in 11 per cent of cases. There was, however, 
no difference in the nature of the structural anoma- 
lies between these two subsets. Polyhydramnios 
was seen in approximately 20 per cent of trisomies, 
mainly associated with gastrointestinal tract 
anomalies, and in 25 per cent of structurally 
abnormal chromosomes, mainly associated with 
skeletal, cardiac, and central nervous system 
pathology. 
Birth weight was below the tenth centile for 
weight by gestation in at least half of the chromo- 
somal anomalies, except for Turner syndrome due 
to the presence of hydrops and/or fluid in the cystic 
hygroma. In triploidy, birth weight was below the 
tenth centile for weight by gestation in 90 per cent 
of cases, which together with the high incidence of 
oligohydramnios (67 per cent) explains why half 
(9/18) of the triploidy cases were referred on the 
basis of combined structural pathology and 
S GA/oligoh ydr amnio s . 
Fetal outcome in the presence of a chromosomal 
abnormality was poor; in our study, the neonatal 
survival rate was 12 per cent (20/170), which was 
mainly due to trisomy 21. Early diagnosis of 
structural pathology is therefore essential, since 
it will allow the availability of all modalities of 
obstetric management including pregnancy termi- 
nation. In this study, termination of pregnancy 
took place in over half (95/170) of the cases. 
It can be concluded that referrals for anomaly 
scanning before 20 weeks are mainly based on 
single-organ pathology, whereas beyond 20 weeks 
they are based on both single- and multiple-organ 
pathology. Fetuses with Turner syndrome are 
referred at an earlier stage in pregnancy than 
fetuses with other chromosomal anomalies. This 
may be due to the well-defined pathology (cystic 
hygroma, fetal hydrops) as demonstrated by ultra- 
sound. Cystic hygroma whether or not combined 
with fetal hydrops was also the most noticeable 
marker for the early diagnosis of trisomy with 
emphasis on trisomy 21. Oligohydramnios is often 
associated with triploidy, whereas polyhydramnios 
occurs with trisomies, in particular in gastrointes- 
tinal anomalies with trisomy 21. The sonographic 
identification of structural anomalies for screening 
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chromosomal aberrations was of limited value, 
because of either late diagnosis or the high fatality 
rate of the lesions. The late diagnosis is partly 
determined by the lack of an established national 
sonographic screening programme below 20 weeks 
of gestation in The Netherlands. 
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